US Patent 11773392 AAV treatment of Huntington's disease
Patent 11773392 was granted and assigned to University of Massachusetts on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+311 characters)
US Patent 11773392 AAV treatment of Huntington's disease
Article
Patent abstract
Aspects of the disclosure relate to compositions and methods useful for treating Huntington's disease. In some embodiments, the disclosure provides interfering nucleic acids (e.g., artificial miRNAs) targeting the huntingtin gene (HTT) and methods of treating Huntington's disease using the same.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christian Mueller
Edith L. Pfister
Neil Aronin
Date of Patent
October 3, 2023
Patent Application Number
17326400
Date Filed
May 21, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11773392 AAV treatment of Huntington's disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
